- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05022992
Effects of a Single Bout of Resistance Training Session on Hormonal Response in Pre-pubertal and Pubertal Boys
: Resistance training induces strength gains in both children and adolescents. Exercise training is linked to anabolic functions through the GH-IGF-I axis. This has been demonstrated in studies showing a higher activity of GH and IGF-I in fitter adolescents and adults. Exercise also stimulates pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) that suppress the GH-IGF-I axis. This has been observed in endurance-type training, while resistance training has received less attention.
Boys experience a significant physiological muscle-growth change during puberty that is associated with increases in boys androgen levels. How maturation affects the hormonal response to resistance training in boys is unclear. Therefore, the purpose of the study is to compare the acute effects of a single bout of resistance training on hormones and pro-inflammatory cytokines in pre-pubertal and pubertal boys.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Preliminary measurements:
Preliminary testing will include anthropometric measurements of body mass, height, body fat percentage, and lean leg volume (LLV). The maturation stage will be determined according to the Tanner scale. There will also be an assessment of maximal strength testing to determine exercise intensity for each individual. Two familiarization sessions will be conducted for muscular strength before the muscular strength testing session.
Main trial A venous blood sample will be collected pre-exercise at resting condition. The trial will start with a standardized warm-up followed by a short (20-30 min), high-intensity whole-body resistance training session. Venous blood samples will be collected immediately after the completion of the training session and during the recovery period.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Apostolos Theos, PhD
- Telefoonnummer: +46702811565
- E-mail: apostolos.theos@umu.se
Studie Locaties
-
-
Västerbotten
-
Umeå, Västerbotten, Zweden, 901 87
- Umeå Movement and Exercise Laboratory, Umeå University
-
Contact:
- Apostolos Theos, PhD
- Telefoonnummer: +46702811565
- E-mail: apostolos.theos@umu.se
-
Contact:
- Tobias Stenlund, PhD
- Telefoonnummer: +46907868040
- E-mail: tobias.stenlund@umu.se
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Healthy boys (n=40)
- Physically active, defined as a minimum of 2 years experience in a sports club
- Biological age range: 20 pre-pubertal (Tanner I-II) - 20 pubertal (Tanner III-IV) boys
- No previous experience of structured resistance training
Exclusion Criteria:
- Chronic diseases that affect full participation
- Injuries that limit full participation
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Resistance Training Session
Resistance training.
Heavy resistance training.
10 reps x 3 set of upper- and lower-body resistance exercises
|
Both groups will perform a resistance training session consisted of 10 reps x 3 set of upper- and lower-body resistance exercises.
|
|
Geen tussenkomst: Control
Control activity.
None-exercising.
30 min of rest
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Growth Hormone Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood Concentration of Growth Hormone
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Growth Hormone Post exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood Concentration of Growth Hormone
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Growth Hormone 15 minutes post exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood Concentration of Growth Hormone
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Growth Hormone 30 minutes post exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood Concentration of Growth Hormone
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Insulin-like Growth Factor-1 Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Insulin-like Growth Factor-1
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Insulin-like Growth Factor-1 Post exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Insulin-like Growth Factor-1
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Insulin-like Growth Factor-1 15 minutes Post exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Insulin-like Growth Factor-1
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Insulin-like Growth Factor-1 30 minutes Post exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Insulin-like Growth Factor-1
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cortisol Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Cortisol
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Cortisol Post exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Cortisol
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Cortisol 15 minutes Post exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Cortisol
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Cortisol 30 minutes Post exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Cortisol
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Testosterone Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of testosterone
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Testosterone Post Exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of testosterone
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Testosterone 15 minutes Post Exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of testosterone
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Testosterone 30 minutes Post Exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of testosterone
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Interleukin-6 Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Interleukin-6
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Interleukin-6 Post Exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Interleukin-6
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Interleukin-6 15 minutes Post Exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Interleukin-6
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Interleukin-6 30 minutes Post Exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Interleukin-6
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Interleukin-1 alpha Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Interleukin-1 alpha
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Interleukin-1 alpha Post Exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Interleukin-1 alpha
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Interleukin-1 alpha 15 minutes Post Exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Interleukin-1 alpha
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Interleukin-1 alpha 30 minutes Post Exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Interleukin-1 alpha
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Tumor Necrosis Factor alpha Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Tumor Necrosis Factor alpha
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Tumor Necrosis Factor alpha Post Exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Tumor Necrosis Factor alpha
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Tumor Necrosis Factor alpha 15 minutes Post Exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Tumor Necrosis Factor alpha
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Tumor Necrosis Factor alpha 30 minutes Post Exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Tumor Necrosis Factor alpha
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
|
Sex Hormone Binding Globulin Baseline
Tijdsspanne: Baseline testing before the exercise intervention (Pre values)
|
Blood concentration of Sex Hormone Binding Globulin
|
Baseline testing before the exercise intervention (Pre values)
|
|
Change from Baseline Baseline Sex Hormone Binding Post Exercise
Tijdsspanne: Right after the completion of the exercise intervention (Post values)
|
Blood concentration of Sex Hormone Binding Globulin
|
Right after the completion of the exercise intervention (Post values)
|
|
Change from Baseline Baseline Sex Hormone Binding 15 minutes Post Exercise
Tijdsspanne: 15 minutes after the completion of the exercise intervention (Post-15 values)
|
Blood concentration of Sex Hormone Binding Globulin
|
15 minutes after the completion of the exercise intervention (Post-15 values)
|
|
Change from Baseline Sex Hormone Binding Globulin 30 minutes Post Exercise
Tijdsspanne: 30 minutes after the completion of the exercise intervention (Post-30 values)
|
Blood concentration of Sex Hormone Binding Globulin
|
30 minutes after the completion of the exercise intervention (Post-30 values)
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Apostolos Theos, PhD, Umeå University
Studie record data
Bestudeer belangrijke data
Studie start (Verwacht)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 2020-03179
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Cytokinen
-
Materno-Perinatal Hospital of the State of MexicoUniversidad Autonoma del Estado de Mexico; Ciprés Grupo Médico CGM SCVoltooidCorrelatie van cytokines en antropometrie tijdens de zwangerschapMexico
-
Mustafa Kemal UniversityVoltooidParodontale behandeling, cytokinesKalkoen
-
University Hospital, Basel, SwitzerlandVoltooidEndocarditis | Cardiopulmonale Chirurgie | Peri-operatieve cytokines-niveausZwitserland
-
Associação Pan-Americana Multidisciplinar de EndocanabinologiaNog niet aan het wervenKwaliteit van het leven | Pijn | Slaap | Pro- en anti-inflammatoire cytokinesBrazilië
-
Fakultas Kedokteran Universitas PadjadjaranActief, niet wervendOntsteking | Zwangerschap Complicaties | Bloedarmoede door ijzertekort tijdens de zwangerschap | Hepcidine | Moringa oleifera | Cytokines (IL-1, IL-6)Indonesië
Klinische onderzoeken op Resistance Training
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtVoltooid
-
University of California, San DiegoVoltooidAutisme Spectrum Stoornis | Autistische stoornisVerenigde Staten
-
Hacettepe UniversityWervingBorstkanker | Aerobic oefening | Weerstand Oefening | Bovenste extremiteitTurkije (Türkiye)
-
Northeastern UniversityOregon Health and Science University; University of California, RiversideWerving
-
Karolinska InstitutetRegion Stockholm; Stiftelsen Sunnerdahls Handikappfond; Swedish Foundation for... en andere medewerkersVoltooidAandachtsstoornisZweden
-
VA Office of Research and DevelopmentVoltooidZiekte van Parkinson | Milde cognitieve stoornisVerenigde Staten
-
University of MinnesotaNational Institute on Aging (NIA)VoltooidDementie | Ziekte van AlzheimerVerenigde Staten
-
Karabuk UniversityThe Scientific and Technological Research Council of TurkeyVoltooidOefening | Telerevalidatie | Teksthals syndroomTurkije (Türkiye)
-
Istinye UniversityActief, niet wervendAtletische prestatie | Sportfysiotherapie | Voetbalspelers | SportprestatiesKalkoen
-
Chang Gung UniversityVoltooidGezonde ouderenTaiwan